Hepatic Glucose Production in Diabetes

Hepatic glucose production is a central feature of diabetes, particularly in type 2 diabetes, where the liver's gluconeogenic activity becomes dysregulated. Insulin resistance in the liver prevents insulin from exerting its normal inhibitory effect on glucose output, resulting in excessive hepatic glucose production. This dysregulation contributes significantly to hyperglycemia, especially during fasting. Furthermore, increased glucose production is associated with the development of non-alcoholic fatty liver disease, which complicates diabetes management. Targeting hepatic glucose production through medications, such as metformin and GLP-1 agonists, can help normalize blood glucose levels and improve metabolic health.